Fasprin
- Product NDC
- 10597-559
- 11-digit product format
- 105970559
- Labeler code
- 10597
- Product ID
- 10597-559_5108bdca-1454-4353-b55f-e31da8ed4f4f
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Aspirin
- Dosage form
- TABLET, ORALLY DISINTEGRATING
- Route
- ORAL
- Labeler
- Nobel Laboratories, LLC
- Application
- part343
- Marketing category
- OTC MONOGRAPH FINAL
- Marketing start
- 2006-09-20
- Marketing end
- 0000-00-00
- Substance
- ASPIRIN
- Active strength
- 81 mg/1
- NDC exclude flag
- E
- Listing certified through
- 2018-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 10597-559-05 | Fasprin | 30 in 1 BOX | TABLET, ORALLY DISINTEGRATING | 30 | | 1 |
| 10597-559-06 | Fasprin | 100 in 1 BOX | TABLET, ORALLY DISINTEGRATING | 100 | | 1 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| ASPIRIN | ACTIVE INGREDIENT | R16CO5Y76E | FASPRIN (ASPIRIN) TABLET, ORALLY DISINTEGRATING [NOBEL LABORATORIES, LLC] | 1 | |
| ASPIRIN | ACTIVE MOIETY | R16CO5Y76E | FASPRIN (ASPIRIN) TABLET, ORALLY DISINTEGRATING [NOBEL LABORATORIES, LLC] | 1 | |
| CITRIC ACID MONOHYDRATE | INACTIVE INGREDIENT | 2968PHW8QP | FASPRIN (ASPIRIN) TABLET, ORALLY DISINTEGRATING [NOBEL LABORATORIES, LLC] | 1 | |
| CROSPOVIDONE | INACTIVE INGREDIENT | 68401960MK | FASPRIN (ASPIRIN) TABLET, ORALLY DISINTEGRATING [NOBEL LABORATORIES, LLC] | 1 | |
| D&C YELLOW NO. 10 | INACTIVE INGREDIENT | 35SW5USQ3G | FASPRIN (ASPIRIN) TABLET, ORALLY DISINTEGRATING [NOBEL LABORATORIES, LLC] | 1 | |
| GLUCOSAMINE | INACTIVE INGREDIENT | N08U5BOQ1K | FASPRIN (ASPIRIN) TABLET, ORALLY DISINTEGRATING [NOBEL LABORATORIES, LLC] | 1 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | FASPRIN (ASPIRIN) TABLET, ORALLY DISINTEGRATING [NOBEL LABORATORIES, LLC] | 1 | |
| SODIUM STEARYL FUMARATE | INACTIVE INGREDIENT | 7CV7WJK4UI | FASPRIN (ASPIRIN) TABLET, ORALLY DISINTEGRATING [NOBEL LABORATORIES, LLC] | 1 | |
| SORBITOL | INACTIVE INGREDIENT | 506T60A25R | FASPRIN (ASPIRIN) TABLET, ORALLY DISINTEGRATING [NOBEL LABORATORIES, LLC] | 1 | |
| ZINC GLUCONATE | INACTIVE INGREDIENT | U6WSN5SQ1Z | FASPRIN (ASPIRIN) TABLET, ORALLY DISINTEGRATING [NOBEL LABORATORIES, LLC] | 1 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 10597-559 | FASPRIN (ASPIRIN) TABLET, ORALLY DISINTEGRATING [NOBEL LABORATORIES, LLC] | 1 | Legacy NDC, 2 package rows | 20101201_73859ea9-01a0-4c3d-97d4-17b9d3378899.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Status |
|---|
| 10597-559-05 | 10597055905 | 30 in 1 BOX | Historical |
| 10597-559-06 | 10597055906 | 100 in 1 BOX | Historical |